Work

Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.

Year: 2003

Type: article

Abstract: The notion that SEBMs[3][1] can predict the effectiveness of chemopreventive agents against carcinogenesis in humans has motivated tremendous efforts to development of these compounds [(1][2], [2][3], [3)][4] . Successful development of useful SEBMs in AIDS and cardiovascular disease seems to

Source: PubMed

Authors: William B Armstrong, Thomas H Taylor, Frank L Meyskens

Institutions: University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center

Language: English

Topic: Carcinogens and Genotoxicity Assessment

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: CANCER PREVENTION BY PROTEASE INHIBITORS, Cancer Center Support Grant